NASDAQ NMS - GLOBAL MARKET · ACOG
-1.29% · -$0.1100 · Vol 56.7K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Alpha Cognition Inc

Alpha Cognition Inc

Biotechnology
$8.41

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is ACOG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for ACOG are being assembled.
About Alpha Cognition Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
71
Country
CA

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$8.73
Day high
$8.80
Day low
$8.40
Previous close
$8.52
52W high
$8.80
-4.43% from high
52W low
$8.40
2% of range
Market cap
$183.1M
EPS
$-1.4000
Shares out
21.8M
Volume
56.7K
VWAP
$8.60
Price history computed in-house
SMA 50 $8.41 · above
SMA 200 $8.41 · above
52W position 2%
Veridion warehouse edge

Warehouse intelligence for ACOG.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

ACOG insider activity

Alpha Cognition Inc

Score
Coverage building
Pressure
Net buying
Filings
43
Buys / sells
42 / 1
Net value
$3.3M
Insiders
5
Named filers
OI
Opaleye Management Inc.
Insider
Leadership
DL
D'Angelo Lauren
Insider
Leadership
WJ
Wills Robert James
Insider
Leadership
Cluster

2 insiders bought in the last 90 days

Net pressure

Net buying: $3.3M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-152026-06-15Opaleye Management Inc.Insiderbuy$5.994,5502,652,574$27KSEC Form 4
2026-06-152026-06-12Opaleye Management Inc.Insiderbuy$5.932732,648,024$2KSEC Form 4
2026-06-152026-06-11Opaleye Management Inc.Insiderbuy$5.912,8622,647,751$17KSEC Form 4
2026-06-112026-06-10Opaleye Management Inc.Insiderbuy$5.995,8722,644,889$35KSEC Form 4
2026-06-112026-06-09Opaleye Management Inc.Insiderbuy$5.9824,8562,639,017$149KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 38 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

ACOG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ACOG in this window.
Lobbying spend

ACOG lobbying filings, year to date.

Registered lobbying filings matched to Alpha Cognition Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ACOG in this window.
Latest news · ACOG
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for ACOG.
Options
Sovereign unlock shows live options positioning for ACOG.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.